Glenmark Pharmaceuticals P/E Ratio
GLENMARK • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
55.65
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
55.65
Current Price
₹2173.50
EPS (TTM)
₹37.11
Exchange
NSE
Valuation Signal
Signal
Overvalued
Historical Avg
22.92
Historical Range
10.2 - 42.78
Percentile
100.0%
Sector Context
Sector Average
47.43
Sector Median
25.5
Sector Rank
#11 of 139
Sector Percentile
7.9%
Earnings Breakdown (TTM)
TTM EPS
₹37.74
Sept 2025
₹21.63
Mar 2025
₹0.16
Key P/E Ratio Insights for Glenmark Pharmaceuticals
- Stock appears overvalued with PE of 55.65, suggesting caution for new investments
- Current PE is 142.8% above historical average
- Trading at premium to sector average PE of 47.43
P/E Ratio Historical Trend for Glenmark Pharmaceuticals
Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.
Related Pages for Glenmark Pharmaceuticals
Additional stock information and data for GLENMARK
Historical P/E Ratio Data
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 42.78 | 37.74 | ₹1614.50 | NSE | High |
| 2022 | 16.82 | 31.22 | ₹525.25 | NSE | Moderate |
| 2021 | 13.91 | 36.14 | ₹502.60 | NSE | Low |
| 2020 | 10.2 | 33.9 | ₹345.70 | NSE | Low |
| 2019 | 27.23 | 25.42 | ₹692.15 | NSE | High |
| 2018 | 18.39 | 32.42 | ₹596.10 | NSE | Moderate |
| 2017 | 29.84 | 29.62 | ₹884.00 | NSE | High |
| 2016 | 24.21 | 38.15 | ₹923.75 | NSE | Moderate |
Sector P/E Ratio Comparison
Comparing Glenmark Pharmaceuticals with other companies in Healthcare sector
Sector Average
47.43
Sector Median
25.5
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.83 | ₹31 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.53 | ₹1,133 | Low |
| Amwill Health Care | AMWILL | 5.67 | ₹64 | Low |
| Brooks Laboratories | BROOKS | 6.14 | ₹157 | Low |
| Medicamen Organics | MEDIORG | 6.4 | ₹27 | Low |
| Zenith Drugs | ZENITHDRUG | 6.83 | ₹69 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.15 | ₹2,100 | Low |
| Galaxy Medicare | GML | 7.41 | ₹26 | Low |
| Vasundhara Rasayans | VRL | 9.35 | ₹34 | Low |